These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [TBL] [Abstract][Full Text] [Related]
8. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine. Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Scharpé J; Peetermans WE; Vanwalleghem J; Maes B; Bammens B; Claes K; Osterhaus AD; Vanrenterghem Y; Evenepoel P Am J Kidney Dis; 2009 Jul; 54(1):77-85. PubMed ID: 19339089 [TBL] [Abstract][Full Text] [Related]
11. Effective nasal influenza vaccine delivery using chitosan. Read RC; Naylor SC; Potter CW; Bond J; Jabbal-Gill I; Fisher A; Illum L; Jennings R Vaccine; 2005 Aug; 23(35):4367-74. PubMed ID: 15916838 [TBL] [Abstract][Full Text] [Related]
12. Administration of inactivated trivalent influenza vaccine to parents of high-risk infants in the neonatal intensive care unit. Shah SI; Caprio M; Hendricks-Munoz K Pediatrics; 2007 Sep; 120(3):e617-21. PubMed ID: 17766502 [TBL] [Abstract][Full Text] [Related]
13. Influenza vaccination in adults with asthma: safety of an inactivated trivalent influenza vaccine. Kmiecik T; Arnoux S; Kobryn A; Gorski P J Asthma; 2007 Dec; 44(10):817-22. PubMed ID: 18097856 [TBL] [Abstract][Full Text] [Related]
14. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003. McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455 [TBL] [Abstract][Full Text] [Related]
15. Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine. Muszkat M; Yehuda AB; Schein MH; Friedlander Y; Naveh P; Greenbaum E; Schlesinger M; Levy R; Zakay-Rones Z; Friedman G J Med Virol; 2000 May; 61(1):100-6. PubMed ID: 10745240 [TBL] [Abstract][Full Text] [Related]
16. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial. Cools HJ; Gussekloo J; Remmerswaal JE; Remarque EJ; Kroes AC J Med Virol; 2009 May; 81(5):908-14. PubMed ID: 19319953 [TBL] [Abstract][Full Text] [Related]
17. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. France EK; Glanz JM; Xu S; Davis RL; Black SB; Shinefield HR; Zangwill KM; Marcy SM; Mullooly JP; Jackson LA; Chen R Arch Pediatr Adolesc Med; 2004 Nov; 158(11):1031-6. PubMed ID: 15520339 [TBL] [Abstract][Full Text] [Related]
18. Influenza vaccination and warfarin anticoagulation: a comparison of subcutaneous and intramuscular routes of administration in elderly men. Delafuente JC; Davis JA; Meuleman JR; Jones RA Pharmacotherapy; 1998; 18(3):631-6. PubMed ID: 9620115 [TBL] [Abstract][Full Text] [Related]
19. Effects of acetaminophen on adverse effects of influenza vaccination in health care workers. Aoki FY; Yassi A; Cheang M; Murdzak C; Hammond GW; Seklà LH; Wright B CMAJ; 1993 Nov; 149(10):1425-30. PubMed ID: 8221426 [TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age. Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]